(2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice

https://doi.org/10.1016/0969-8051(94)90161-9Get rights and content

Abstract

Octreotide is labeled with fluorine-18 as a potential radiopharmaceutical for quantitative in vivo mapping of somatostatin receptors. [18F]-fluoroacylation is achieved with n.c.a. 2-[18F]fluoropropionic acid 4-nitrophenylester which is reacted with ϵ-Boc-Lys5-octreotide. After deprotection the desired Nα-[18F]fluoropropionylated octreotide ([18F]SDZ 223–228) is obtained. Final HPLC purification gives rise to radiochemical yields of 65 ± 5% based on the fluoroacylation agent. Binding experiments using rat cortex membranes indicate an affinity for somatostatin receptors of pKi = 8.6 ± 0.2. The biological activity of this SRIF analog is demonstrated by the inhibition of growth hormone release from cultured pituitary cells. The pIC50 in this test system is 8.75, indicating full biological activity. Biodistribution studies with NMRI mice show predominantly renal excretion, rapid blood clearance and only negligible bone activity, i.e. formation of free fluoride.

References (29)

  • H.H. Coenen

    No carrier added 18F-chemistry of radiopharmaceuticals

  • P.K. Garg et al.

    Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity

    Bioconj. Chem.

    (1991)
  • S. Guhlke et al.

    [18F]Fluoroacetic acid and 2-[18F]fluoropropionic acid derivatives as reactive fluoroacylation agents

    J. Label. Compd. Radiopharm.

    (1993)
  • S. Guhlke et al.

    Fluoroacylation agents based on small n.c.a. [18F]fluorocarboxylic acids

    Int. J. Appl. Radiat. Isot.

    (1993)
  • Cited by (88)

    • Targeted Antibodies and Peptides

      2021, Molecular Imaging: Principles and Practice
    • Fluorine-18 radiolabeling of biologics

      2018, Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals Progress in Fluorine Science Series
    • Advances in Imaging: Step Towards Precision Medicine

      2022, Advances in Imaging: Step Towards Precision Medicine
    View all citing articles on Scopus
    View full text